key: cord-0967904-l8o2x7r3
authors: Snell, L. B.; Wang, W.; Alcolea-Medina, A.; Charalampous, T.; Nebbia, G.; Batra, R.; de Jongh, L.; Higgins, F.; Wang, Y.; Edgeworth, J. D.; Curcin, V.
title: First and second SARS-CoV-2 waves in inner London: A comparison of admission characteristics and the effects of the B.1.1.7 variant
date: 2021-03-24
journal: nan
DOI: 10.1101/2021.03.16.21253377
sha: 15bffcddf5b329fd33ed0519511d8236a88e07f8
doc_id: 967904
cord_uid: l8o2x7r3

Introduction: A second wave of SARS-CoV-2 infection spread across the UK in 2020 linked with emergence of the more transmissible B.1.1.7 variant. The emergence of new variants, particularly during relaxation of social distancing policies and implementation of mass vaccination, highlights the need for real-time integration of detailed patient clinical data alongside pathogen genomic data. We linked clinical data with viral genome sequence data to compare patients admitted during the first and second waves of SARS-CoV-2 infection. Methods: Clinical, laboratory and demographic data from five electronic health record (EHR) systems was collected for all cases with a positive SARS-CoV-2 RNA test between March 13th 2020 and February 17th 2021. SARS-CoV-2 viral sequencing was performed using Oxford Nanopore Technology. Descriptive data are presented comparing cases between waves, and between cases of B.1.1.7 and non-B.1.1.7 variants. Results: There were 5810 SARS-CoV-2 RNA positive cases comprising inpatients (n=2341), healthcare workers (n=1549), outpatients (n=874), emergency department (ED) attenders not subsequently admitted (n=532), inter-hospital transfers (n=281) and nosocomial cases (n=233). There were two dominant waves of admissions starting from around March 13th and October 20th, both with a temporally aligned rise in nosocomial cases (n=96 in wave one, n=137 in wave two). 1470 SARS-CoV-2 isolates were successfully sequenced, including 216/838 (26%) admitted cases from wave one, 472/1503 (31%) admitted cases in wave two and 121/233 (52%) nosocomial cases. 400/472 (85%) of sequenced isolates from admitted cases in wave two were the B.1.1.7 variant. The first B.1.1.7 variant was identified on 15th November 2020 and increased rapidly to comprise almost all sequenced isolates in January 2021 (n=600/617, 97%). Females made up a larger proportion of admitted cases in wave two (47.2% vs 41.8%, p=0.012), and in those infected with the B.1.1.7 variant compared to non-B.1.1.7 variants (48.0% vs 41.8%, p=0.042). A diagnosis of frailty was less common in wave two (11.5% v 22.8%, p<0.001) and in the group infected with B.1.1.7 (14.5% v 22.4%, p=0.001). There was no difference in severity on admission between waves, as measured by hypoxia at admission (wave one: 64.3% vs wave two: 65.6%, p=0.658). However, a higher proportion of cases infected with the B.1.1.7 variant were hypoxic on admission compared to other variants (70.0% vs 62.5%, p=0.029). Conclusions: Automated EHR data extraction linked with SARS-CoV-2 genome sequence data provides valuable insight into the evolving characteristics of cases admitted to hospital with COVID-19. The proportion of cases with hypoxia on admission was greater in those infected with the B.1.1.7 variant, which supports evidence the B.1.1.7 variant is associated with more severe disease. The number of nosocomial cases was similar in both waves despite introduction of many infection control interventions before wave two, an observation requiring further investigation.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 24, 2021. ;  https://doi.org/10.1101/2021.03. 16.21253377 doi: medRxiv preprint Conclusions Automated EHR data extraction linked with SARS-CoV-2 genome sequence data provides 58 valuable insight into the evolving characteristics of cases admitted to hospital with COVID- 19 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 24, 2021. ;  https://doi.org/10.1101/2021.03. 16 .21253377 doi: medRxiv preprint Background 65 66 SARS-CoV-2 infection has led to the death of over 1 million individuals worldwide since its emergence in 67 China during December 2019, with over 100,000 deaths reported in the UK. SARS-CoV-2 incidence shows 68 a highly dynamic course often described in waves. The first wave involved community and nosocomial 69 transmission following the introduction of SARS-CoV-2 into a non-immune population. In London, the 70 estimated incidence in the first wave peaked around March 23rd at 2.2% [1] and then rapidly declined 71 following 2 weeks of social distancing and restrictions. Hospital admissions peaked about 1 week later [2] 72 reflecting the median period of symptoms before hospital presentation. 73 74 Incidence of SARS-CoV-2 remained low during the summer months in the UK before a "second wave" of 75 infections, starting in London around the beginning of October [3] . The second wave occurred in a very 76 different environment. Many public health interventions had been introduced such as universal mask use in 77 hospitals [4] and many indoor settings [5] . There was better understanding of risk factors for severe disease 78 [6, 7] , which prompted vulnerable and elderly people to shield. People were urged to work from home when 79 possible [8] . Schools reopened in September and students returned to University probably representing the 80 largest population movement around the country preceding the second wave [9] . There was also rapid scale 81 up of community testing with contact tracing and isolation. Genome sequencing identified new variants, 82 including the B.1.1.7 variant which was first identified around the South East of England and spread rapidly 83 as part of the emerging second wave. [10] The B.1.1.7 variant has been associated with increased 84 transmissibility in community studies [11] [12] [13] , and there is evidence from community studies that it may 85 also confer increased mortality [14] [15] [16] [17] . Finally, vaccination is being rolled out at pace prioritising 86 high risk groups and healthcare workers (HCW), with over 25% of the adult population receiving the first dose 87 by mid February 2021 [18] 88 89 These many changes have potential to affect the burden on healthcare systems, and modify the 90 characteristics of cases presenting to hospital including the demographics, co-morbidities and severity of 91 disease associated with SARS-CoV-2 infection. For instance, a report from Japan suggests cases admitted 92 during the second wave are younger, with fewer co-morbidities and with lower markers of disease severity 93 [19] . It is important to understand these changes in real time, to help assess the impact of public health 94 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Currently data are collected in routine clinical systems, alongside which ISARIC WHO CCP-UK collects data 98 as a large prospective cohort study of COVID-19 patients [20] and COG-UK [21] supports collection of isolates 99 for genome sequencing. As SARS-CoV-2 prevalence falls to potentially become endemic, informatics teams 100 would benefit from an automated mechanism to iteratively extract and link patient and SARS-CoV-2 genomic 101 data for local healthcare planning and to support national and international research studies. We therefore is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Whole genome sequencing of residual samples from SARS-CoV-2 cases was performed using GridION 152 (Oxford Nanopore Technology), using version 3 of the ARTIC protocol [23] and bioinformatics pipeline [24] . 153 Samples were selected for sequencing if the corrected CT value was 33 or below, or the Hologic Aptima is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Comorbidities and medication history were extracted from the EPR and e-Noting using natural language 172 processing (NLP). Comorbidities were extracted from any of the databases covering the pathway of the cases 173 from arrival in accident and emergency through inpatient general ward and critical care unit, where applicable, 174 to hospital discharge or death. If a comorbidity was not recorded we assume that it was not present. Cases 175 were characterised as having/not having a past medical history of hypertension, cardiovascular disease 176 (stroke, transient ischaemic attack, atrial fibrillation, congestive heart failure, ischaemic heart disease, 177 peripheral artery disease or atherosclerotic disease), diabetes mellitus, chronic kidney disease, chronic 178 respiratory disease (chronic obstructive pulmonary disease, asthma, bronchiectasis or pulmonary fibrosis) 179 and neoplastic disease (solid tumours, haematological neoplasias or metastatic disease). Obesity was 180 defined as either morbid obesity present in the notes, or recorded Body Mass Index (BMI) >= 30 kg/m 2 .

Data management was performed using SQL databases, with analysis carried out on the secure King's Health 182 Partners (KHP) Rosalind high-performance computer infrastructure [26] running Jupyter Notebook 6.0.3, R 183 3.6.3 and Python 3.7.6. Medicines data were extracted using both structured queries and natural language 184 processing tools with medical and drug dictionaries. Additionally, checks on free text data were performed by 185 a cardiovascular clinician to ensure the information was accurate. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint were also detected in the wave two admission cohort. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint General statistics of cases admitted during wave one (n=838) and wave two (n=1503) were compared (Table   226 1). There was only a small difference in mean age (62yrs in wave one v 60yrs in wave two, p=0.019), however 227 admitted cases were more likely to be female in wave two (47.3% v 41.8%, p=0.011). Comparison of 228 comorbidities showed those in wave two were less likely to have a diagnosis of frailty (11.5% v 22.8%, 229 p<0.001), history of stroke (4.3% v 8.6%, p<0.001) or cancer (4.8% v 7.2%, p=0.022). A larger proportion of 230 admitted cases in wave two were obese (29.1% v 24.6%, p=0.02). There was no significant difference in 231 proportion with known comorbidities of diabetes, kidney disease, hypertension, cardiovascular disease or 232 respiratory disease. Laboratory markers were compared between waves (Table 1) . There were small but significant differences, is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint comorbidities between groups are shown in Table 2 , but did not reach statistical significance. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint There were threefold more SARS-CoV-2 RNA positive cases reported by the hospital laboratory in wave two. 278 The interpretation of this increase must recognise the many changes in testing guidelines and testing capacity 279 between the two waves. Testing capacity increased substantially throughout 2020 both in hospital and in the 280 community. Partly due to these capacity limits, during wave one it was not local policy to offer testing to 281 outpatients and those not requiring admission, instead relying on clinical diagnosis. Healthcare workers were 282 not offered occupational health testing until the end of wave one. We therefore restricted comparison to 283 admitted and nosocomial cases. There were almost twice as many admitted cases in wave two compared with wave one (1503 v 838). This 286 is consistent with a higher local community incidence as reported by the ONS infection survey with 3.5% of 287 individuals in London infected in January 2021 [27] , compared with 2.2% of individuals in London at the peak 288 of wave one [1] . The increase in peak hospital occupancy in wave two has also been reported nationally [28] . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Admitted cases in the wave two were also around half as likely to have a diagnosis of frailty, which may be 305 due to fewer admissions from care homes during wave two, which has been reported both nationally [30] 306 and internationally [31] . Additionally, admitted cases were around a third less likely to have cancer in wave 307 two. Both of these reductions may also be as a result of individuals shielding, and therefore at reduced risk 308 for acquiring SARS-CoV-2 infection. Other differences in comorbidities between waves were small and of 309 unclear clinical significance. Those admitted with B.1.1.7 infection were also less likely to be frail, however 310 no other clinically significant difference in co-morbidities was found.

Our findings contrast to those seen in other areas where differences between waves have been compared. 313 For instance, in Japan the second wave had fewer cases, which were younger and less comorbid [19] is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 24, 2021. ;  cases are mechanistically linked and therefore follow the same course, peaking prior to hospitalisations of 331 cases. 332 333 Some healthcare institutions report far fewer nosocomial acquisitions; for instance an academic hospital in 334 Boston, USA reported only 2 nosocomial cases in over 9000 admissions [33] . This could be due to greater 335 availability of side rooms for isolation or their use of N95 masks by HCWs, which may decrease transmission 336 between HCWs and patients. In contrast, current UK public health policy recommends surgical facemasks 337 for patient interactions unless performing aerosol generating procedures [34] . This incidence of nosocomial 338 infection is a major challenge for UK healthcare institutions, with associated crude mortality at around 30% 339 during the first wave [35, 36] . For this reason it will be important to further investigate the factors involved in 340 nosocomial acquisition in both waves. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 24, 2021. ; is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 24, 2021. ; is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint cohort for non B.1.1.7 variant and B.1.1.7 . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted March 24, 2021. ; https://doi.org/10.1101/2021.03.16.21253377 doi: medRxiv preprint

SARS-CoV-2 infection in London, England: changes to community point prevalence around lockdown time

New variant of SARS-CoV-2 in UK causes surge of COVID-19

Face masks and coverings to be worn by all NHS hospital staff and visitors

Face coverings: when to wear one, exemptions, and how to make your own

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention

Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis

Boris Johnson unveils winter of Covid-19 restrictions. Financial Times

Universities to stay open during England's second Covid lockdown

Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations

Investigation of novel SARS-COV-2 variant: Variant of Concern 202012/01 (PDF). Public Health England PHE

European Centre for Disease Prevention and Control. Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom

Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data

New and Emerging Respiratory Virus Threats Advisory Group. NERVTAG meeting on SARS-CoV-2 variant under investigation VUI-202012/01. 2020

Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

Boris Johnson says "great strides" made with vaccinations but many are yet to be reached -as it happened. The Guardian

First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

COG-UK) consortiumcontact@cogconsortium.uk. An integrated national scale SARS-CoV-2 genomic surveillance network

Surveillance definitions for COVID-19

nCoV-2019 sequencing protocol v1 (protocols.io.bbmuik6w). protocols.io. ZappyLab, Inc.; 2020

Artic Network

Acknowledging -Rosalind research computing infrastructure

COVID-19) Infection Survey, UK -Office for National Statistics

Hospitals admit one third of COVID patients in a single month

Scientific Advisory Group for Emergencies. NERVTAG: Update note on B.1.1.7 severity

Deaths involving COVID-19 in the care sector, England and Wales -Office for National Statistics

Second versus first wave of COVID-19 deaths: shifts in age distribution and in nursing home fatalities

Epidemiologic comparison of the first and second waves of coronavirus disease in Babol, North of Iran

Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical Center

COVID-19: infection prevention and control (IPC)

Nosocomial COVID-19 infection: examining the risk of mortality. The COPE-Nosocomial Study (COVID in Older PEople)

Combined epidemiological and genomic analysis of nosocomial SARS-CoV-2 transmission identifies community social distancing as the dominant intervention reducing outbreaks. bioRxiv. medRxiv